Security Snapshot

ReposiTrak, Inc. - Common stock (TRAK) Institutional Ownership

CUSIP: 700215304

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

91

Shares (Excl. Options)

6,921,207

Price

$12.37

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / Common stock
Symbol
TRAK on NYSE
Shares outstanding
18,404,688
Price per share
$7.60
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,921,207
Total reported value
$85,665,650
% of total 13F portfolios
0%
Share change
-46,851
Value change
-$879,651
Number of holders
91
Price from insider filings
$7.60
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • TRAK - ReposiTrak, Inc. - Common stock is tracked under CUSIP 700215304.
  • 91 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 91 to 20 between Q4 2025 and Q1 2026.
  • Reported value moved from $85,665,650 to $425,047.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 91 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 700215304?
CUSIP 700215304 identifies TRAK - ReposiTrak, Inc. - Common stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of ReposiTrak, Inc. - Common stock (TRAK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RICE HALL JAMES & ASSOCIATES, LLC 4.7% $18,043,721 853,131 Rice Hall James & Associates, LLC 31 Mar 2025

As of 31 Dec 2025, 91 institutional investors reported holding 6,921,207 shares of ReposiTrak, Inc. - Common stock (TRAK). This represents 38% of the company’s total 18,404,688 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ReposiTrak, Inc. - Common stock (TRAK) together control 35% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Handelsbanken Fonder AB 6.3% 1,159,100 -30% 0.04% $14,338,000
RICE HALL JAMES & ASSOCIATES, LLC 4.3% 793,858 +6.4% 0.54% $9,820,023
VANGUARD GROUP INC 4% 735,667 +1.1% 0% $9,100,201
BlackRock, Inc. 3.8% 692,129 +2.8% 0% $8,561,635
ASHFORD CAPITAL MANAGEMENT INC 3.7% 679,581 -17% 0.94% $8,406,417
BANK OF MONTREAL /CAN/ 1.5% 279,461 0% $3,456,933
GEODE CAPITAL MANAGEMENT, LLC 1.4% 265,298 +0.33% 0% $3,282,320
INGALLS & SNYDER LLC 1.2% 223,392 +13% 0.1% $2,763,000
STATE STREET CORP 1.1% 202,934 +4.2% 0% $2,514,324
RENAISSANCE TECHNOLOGIES LLC 1% 188,263 -4% 0% $2,328,813
Bank of New York Mellon Corp 0.72% 132,825 +34% 0% $1,643,039
STIFEL FINANCIAL CORP 0.7% 129,275 +139% 0% $1,599,139
Squarepoint Ops LLC 0.54% 99,830 +40% 0% $1,234,897
CITADEL ADVISORS LLC 0.54% 99,119 +49% 0% $1,226,102
NORTHERN TRUST CORP 0.47% 86,023 -4% 0% $1,064,104
Prescott Group Capital Management, L.L.C. 0.46% 84,992 +148% 0.1% $1,051,351
MORGAN STANLEY 0.45% 83,373 +79% 0% $1,031,325
MARSHALL WACE, LLP 0.42% 77,617 +283% 0% $960,121
Lunt Capital Management, Inc. 0.32% 58,292 +7.8% 0.27% $721,072
TWO SIGMA INVESTMENTS, LP 0.31% 56,476 -19% 0% $698,608
GSA CAPITAL PARTNERS LLP 0.3% 54,529 +269% 0.06% $675,000
Qube Research & Technologies Ltd 0.29% 53,649 +151% 0% $663,638
GOLDMAN SACHS GROUP INC 0.28% 52,050 +173% 0% $643,858
TWO SIGMA ADVISERS, LP 0.24% 43,900 -21% 0% $543,043
COLDSTREAM CAPITAL MANAGEMENT INC 0.22% 40,081 +0.1% 0.01% $496,202

Institutional Holders of ReposiTrak, Inc. - Common stock (TRAK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 56,094 $425,047 -$14,561,578 $7.60 20
2025 Q4 6,921,207 $85,665,650 -$879,651 $12.37 91
2025 Q3 6,992,396 $103,635,186 -$553,569 $14.82 89
2025 Q2 6,947,416 $136,522,305 +$7,558,812 $19.65 86
2025 Q1 6,573,039 $133,248,504 +$1,958,635 $20.27 84
2024 Q4 6,463,665 $143,045,461 +$6,502,676 $22.13 91
2024 Q3 6,161,020 $113,838,772 +$4,315,222 $18.47 78
2024 Q2 5,875,179 $89,832,460 +$6,956,779 $15.29 70
2024 Q1 5,369,880 $85,111,604 +$8,995,592 $15.85 62
2023 Q4 4,961,746 $49,783,213 +$2,410,698 $10.01 60
2023 Q3 4,834,786 $42,352,819 -$790,833 $8.76 50
2023 Q2 4,853,312 $48,968,880 +$1,946,325 $10.09 42
2023 Q1 4,625,090 $29,130,059 +$563,464 $6.28 40
2022 Q4 4,544,788 $22,490,241 -$508,351 $4.95 41
2022 Q3 4,643,814 $24,838,968 -$2,454,291 $5.35 36
2022 Q2 5,078,375 $22,343,796 -$1,081,519 $4.40 36
2022 Q1 5,318,261 $28,074,956 -$2,271,262 $5.28 44
2021 Q4 5,738,630 $33,336,341 -$2,621,817 $5.81 38
2021 Q3 6,205,979 $33,819,308 +$983,147 $5.45 42
2021 Q2 6,033,411 $33,248,890 -$3,293,064 $5.51 47
2021 Q1 6,595,905 $40,296,909 +$3,456,682 $6.11 52
2020 Q4 6,047,191 $28,964,639 +$936,987 $4.79 50
2020 Q3 5,744,731 $28,319,201 +$148,965 $4.93 43
2020 Q2 5,735,473 $24,258,971 +$299,466 $4.23 47
2020 Q1 5,737,230 $21,800,285 -$658,920 $3.80 31
2019 Q4 5,847,678 $29,590,380 +$2,546,117 $5.06 36
2019 Q3 4,929,951 $28,443,765 +$1,063,830 $5.77 41
2019 Q2 4,794,827 $25,696,142 -$8,119,299 $5.36 44
2019 Q1 5,536,187 $44,232,396 -$33,484 $7.99 50
2018 Q4 5,542,441 $33,084,409 -$1,744,165 $5.97 51
2018 Q3 5,696,776 $57,523,404 +$1,768,459 $10.10 53
2018 Q2 5,522,822 $43,630,444 -$4,929,292 $7.90 49
2018 Q1 6,045,637 $52,898,682 -$1,042,409 $8.75 52
2017 Q4 6,616,086 $63,186,051 +$4,979,700 $9.55 59
2017 Q3 6,047,784 $73,482,519 +$5,027,914 $12.15 51
2017 Q2 5,635,747 $68,470,564 -$5,011,648 $12.15 63
2017 Q1 6,015,616 $74,289,296 +$9,335,234 $12.35 62
2016 Q4 5,862,989 $74,486,280 +$5,280,194 $12.70 64
2016 Q3 5,393,021 $63,630,307 +$2,550,946 $11.80 60
2016 Q2 5,196,462 $46,611,294 -$3,934,631 $8.97 48
2016 Q1 5,632,331 $50,930,000 -$3,040,199 $9.04 47
2015 Q4 5,876,531 $69,643,829 +$973,873 $11.91 53
2015 Q3 5,722,654 $60,495,304 +$441,257 $10.57 47
2015 Q2 5,660,029 $70,137,828 +$13,740,004 $12.39 52
2015 Q1 4,116,662 $56,731,076 +$5,400,128 $13.78 50
2014 Q4 3,803,460 $34,308,669 +$2,389,361 $9.02 49
2014 Q3 2,729,241 $26,912,525 +$1,273,073 $9.86 40
2014 Q2 2,581,524 $28,110,362 +$2,331,775 $10.89 48
2014 Q1 2,384,840 $22,835,154 +$2,367,698 $9.08 27
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .